Generic and condition-specific outcome measures for people with osteoarthritis of the knee

被引:266
作者
Brazier, JE
Harper, R
Munro, J
Walters, SJ
Snaith, ML
机构
[1] Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England
[2] Univ Sheffield, Sch Med, Inst Bone & Joint Med, Sheffield, S Yorkshire, England
关键词
osteoarthritis; knee; health-related quality of life; outcomes;
D O I
10.1093/rheumatology/38.9.870
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The aims of this study were to evaluate two condition-specific and two generic health status questionnaires for measuring health-related quality of life in patients with osteoarthritis (OA) of the knee, and to offer guidance to clinicians and researchers in choosing between them. Methods. Patients were recruited From two settings: 118 from knee surgery waiting lists and 112 from rheumatology clinics. Four self-completion questionnaires [Western Ontario and McMaster University Osteoarthritis Index(WOMAC), Health Assessment Questionnaire (HAQ), Short Form-36 (SF-36) and Euroqol] were sent to subjects on two occasions 6 months apart. Construct validity, convergent validity, internal consistency and responsiveness were examined using primarily non-parametric methods. Results. Ail instruments proved satisfactory in terms of ease of use, acceptability to patients, internal consistency and reliability. In the surgical group, the OA-specific WOMAC performed better than the HAQ and the generic measures in terms of validity and responsiveness to change, whereas in the rheumatology group the SF-36 was more responsive. Conclusion. WOMAC is the instrument of choice for evaluating the outcome of knee replacement surgery in OA. The SE-36 provides a more general insight into patients' health and may be more responsive to change than the WOMAC in a heterogeneous rheumatology clinic population. Researchers wishing to undertake an economic evaluation might consider the EQ-5D for a surgical, but not a rheumatology clinic group.
引用
收藏
页码:870 / 877
页数:8
相关论文
共 22 条
[1]  
[Anonymous], 1992, MEASURES NEED OUTCOM
[2]  
[Anonymous], STAT POWER ANAL BEHA
[3]  
BELLAMY N, 1988, J RHEUMATOL, V15, P1833
[4]  
BOMBARDIER C, 1995, MED CARE, V33, pAS131
[5]  
BRAZIER J, 1996, MEASURING HLTH OUTCO
[6]   VALIDATING THE SF-36 HEALTH SURVEY QUESTIONNAIRE - NEW OUTCOME MEASURE FOR PRIMARY CARE [J].
BRAZIER, JE ;
HARPER, R ;
JONES, NMB ;
OCATHAIN, A ;
THOMAS, KJ ;
USHERWOOD, T ;
WESTLAKE, L .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6846) :160-164
[7]  
FITZPATRICK R, 1992, BRIT J RHEUMATOL, V31, P87
[8]   MEASURING RELEVANT CHANGE - AN EMERGING CHALLENGE IN RHEUMATOLOGIC CLINICAL-TRIALS [J].
FORTIN, PR ;
STUCKI, G ;
KATZ, JN .
ARTHRITIS AND RHEUMATISM, 1995, 38 (08) :1027-1030
[9]   THE SF-36 HEALTH SURVEY QUESTIONNAIRE - AN OUTCOME MEASURE SUITABLE FOR ROUTINE USE WITHIN THE NHS [J].
GARRATT, AM ;
RUTA, DA ;
ABDALLA, MI ;
BUCKINGHAM, JK ;
RUSSELL, IT .
BMJ-BRITISH MEDICAL JOURNAL, 1993, 306 (6890) :1440-1444
[10]  
Griffiths G., 1995, Inflammopharmacology, V3, P1, DOI 10.1007/BF02659105